SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Shigeru Yoshida, Junko Hattori, Masakazu Matsuda, Kiyomi Okada, Yukumasa Kazuyama, Osamu Hashimoto, Shiro Ibe, Shin-ichi Fujisawa, Hitoshi Chiba, Masashi Tatsumi, Shingo Kato, Wataru Sugiura, Japanese External Quality Assessment Program to Standardize HIV-1 Drug-Resistance Testing (JEQS2010 Program) UsingIn VitroTranscribed RNA as Reference Material, AIDS Research and Human Retroviruses, 2015, 31, 3, 318

    CrossRef

  2. 2
    KASL clinical practice guidelines: Management of Hepatitis C, Clinical and Molecular Hepatology, 2014, 20, 2, 89

    CrossRef

  3. 3
    Manal M. Abd-Elgawad, Nahed M. Baddour, Mona A.E. Salem, Chronic hepatitis C in children: Clinical spectrum and histopathological study, Alexandria Journal of Medicine, 2013, 49, 4, 363

    CrossRef

  4. 4
    J. Angulo, K. Pino, C. Pavez, F. Biel, P. Labbé, J. F. Miquel, A. Soza, M. López-Lastra, Genetic variations in host IL28B links to the detection of peripheral blood mononuclear cells–associated hepatitis C virus RNA in chronically infected patients, Journal of Viral Hepatitis, 2013, 20, 4
  5. 5
    Tatsuya Kanto, Michiyo Inoue, Tsugiko Oze, Masanori Miyazaki, Mitsuru Sakakibara, Naruyasu Kakita, Tokuhiro Matsubara, Koyo Higashitani, Hideki Hagiwara, Sadaharu Iio, Kazuhiro Katayama, Eiji Mita, Akinori Kasahara, Naoki Hiramatsu, Tetsuo Takehara, Norio Hayashi, Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients, Journal of Gastroenterology, 2012, 47, 2, 169

    CrossRef

  6. 6
    Manal Aly Abdel Khalek, Amal Mohamad El-barbary, Ferial Salah Elkalla, Salwa Abdel-Moneim Essa, Prevalence of peripheral neuropathy in Egyptian hepatitis C virus patients: Correlation to some clinical and laboratory parameters, The Egyptian Rheumatologist, 2012, 34, 3, 91

    CrossRef

  7. 7
    Sandro La Vignera, Rosita A. Condorelli, Enzo Vicari, Rosario D'Agata, Aldo E. Calogero, Sperm DNA damage in patients with chronic viral C hepatitis, European Journal of Internal Medicine, 2012, 23, 1, e19

    CrossRef

  8. 8
    Christopher M. Moore, Magdalena George, David H. Van Thiel, Consensus Interferon Used to Treat Prior Partial-Responders to Pegylated Interferon Plus Ribavirin, Digestive Diseases and Sciences, 2011, 56, 10, 3032

    CrossRef

  9. 9
    Mohamed Ibrahim Shabana, Ayman Rashad Amer, Abeir Osman Dabbous, Amani Ahmed Al-Sunni, Hearing profile in hepatitis C virus patients under dual treatment with interferon and ribavirin, Audiological Medicine, 2010, 8, 3, 142

    CrossRef

  10. You have free access to this content10
    Marc G. Ghany, Doris B. Strader, David L. Thomas, Leonard B. Seeff, Diagnosis, management, and treatment of hepatitis C: An update, Hepatology, 2009, 49, 4
  11. 11
    Young-Sook Cho, Young-Hoon Kim, Kyung-Hee Lee, Hye-Sun Jang, Kyung-Ah Hwang, Yoo-Li Kim, Hyun-Young Chi, Evaluation of the Real-Q HCV Quantification Kit, Korean Journal of Clinical Microbiology, 2009, 12, 2, 72

    CrossRef

  12. 12
    S. Zeuzem, T. Berg, B. Moeller, H. Hinrichsen, S. Mauss, H. Wedemeyer, C. Sarrazin, D. Hueppe, E. Zehnter, M. P. Manns, Expert opinion on the treatment of patients with chronic hepatitis C, Journal of Viral Hepatitis, 2009, 16, 2
  13. 13
    Shang-Pang Huang, Gow-Jen Shieh, Jiunn-Liang Ko, Zen-Yi Weng, Jaung-Geng Lin, Jung-Chou Chen, Inhibition of subgenomic hepatitis C virus RNA transcription by chinese herbal extracts, Pharmaceutical Biology, 2009, 47, 2, 111

    CrossRef

  14. 14
    Elisa Gruppioni, Francesco Vasuri, Michelangelo Fiorentino, Elisa Capizzi, Annalisa Altimari, Maria G. Pirini, Gian L. Grazi, Deborah Malvi, Walter F. Grigioni, Antonia DʼErrico-Grigioni, Real-time Quantitative Assay for Routine Testing of HCV RNA in Formalin-fixed, Paraffin-embedded Liver Samples, Diagnostic Molecular Pathology, 2009, 18, 4, 232

    CrossRef

  15. 15
    Tahany Awad, Kristian Thorlund, Goran Hauser, Mahasen Mabrouk, Davor Stimac, Christian Gluud, Tahany Awad, Cochrane Database of Systematic Reviews, 2009,

    CrossRef

  16. 16
    Tahany Awad, Kristian Thorlund, Goran Hauser, Mahasen Mabrouk, Davor Stimac, Christian Gluud, Tahany Awad, Cochrane Database of Systematic Reviews, 2009,

    CrossRef

  17. 17
    Tahany Awad, Kristian Thorlund, Goran Hauser, Mahasen Mabrouk, Davor Stimac, Christian Gluud, Tahany Awad, Cochrane Database of Systematic Reviews, 2009,

    CrossRef

  18. 18
    Tahany Awad, Kristian Thorlund, Goran Hauser, Mahasen Mabrouk, Davor Stimac, Christian Gluud, Tahany Awad, Cochrane Database of Systematic Reviews, 2009,

    CrossRef

  19. 19
    Fabrizia Pittaluga, Tiziano Allice, Maria Lorena Abate, Alessia Ciancio, Francesco Cerutti, Silvia Varetto, Giuseppe Colucci, Antonina Smedile, Valeria Ghisetti, Clinical evaluation of the COBAS Ampliprep™/COBAS TaqMan™ for HCV RNA quantitation in comparison with the branched-DNA assay, Journal of Medical Virology, 2008, 80, 2
  20. 20
    Prista Charuworn, Ramsey Cheung, Diagnostic markers for hepatitis virus infection, Expert Opinion on Medical Diagnostics, 2008, 2, 3, 303

    CrossRef

  21. 21
    Christoph Sarrazin, Anette Dragan, Barbara C. Gärtner, Michael S. Forman, Stella Traver, Stefan Zeuzem, Alexandra Valsamakis, Evaluation of an automated, highly sensitive, real-time PCR-based assay (COBAS Ampliprep™/COBAS TaqMan™) for quantification of HCV RNA, Journal of Clinical Virology, 2008, 43, 2, 162

    CrossRef

  22. 22
    Antonio Craxì, Giacomo Laffi, Anna Linda Zignego, Hepatitis C virus (HCV) infection: A systemic disease, Molecular Aspects of Medicine, 2008, 29, 1-2, 85

    CrossRef

  23. 23
    Masanori Miyazaki, Tatsuya Kanto, Michiyo Inoue, Ichiyo Itose, Hideki Miyatake, Mitsuru Sakakibara, Takayuki Yakushijin, Naruyasu Kakita, Naoki Hiramatsu, Tetsuo Takehara, Akinori Kasahara, Norio Hayashi, Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I, Journal of Medical Virology, 2008, 80, 6
  24. 24
    Jee-Fu Huang, Chia-Yen Dai, Ya-Yun Lin, Ming-Lung Yu, Shu-Fen Liu, I-Ling Lin, Ming-Yen Hsieh, Li-Po Lee, Zu-Yau Lin, Shinn-Chern Chen, Ming-Yuh Hsieh, Wen-Yu Chang, Wan-Long Chuang, Performance characteristics of a real-time RT-PCR assay for quantification of hepatitis C virus RNA in patients with genotype 1 and 2 infections, Clinical Chemistry and Laboratory Medicine, 2008, 46, 4

    CrossRef

  25. 25
    Tony Carlsson, Anne Quist, Ola Weiland, Rapid viral response and treatment outcome in genotype 2 and 3 chronic hepatitis C: comparison between two HCV RNA quantitation methods, Journal of Medical Virology, 2008, 80, 5
  26. 26
    M. SIMIN, J. BROK, D. STIMAC, C. GLUUD, L. L. GLUUD, Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C, Alimentary Pharmacology & Therapeutics, 2007, 25, 10
  27. 27
    Mireen Friedrich-Rust, Stefan Zeuzem, Christoph Sarrazin, Current therapy for hepatitis C, International Journal of Colorectal Disease, 2007, 22, 4, 341

    CrossRef

  28. 28
    Ichiyo Itose, Tatsuya Kanto, Michiyo Inoue, Masanori Miyazaki, Hideki Miyatake, Mitsuru Sakakibara, Takayuki Yakushijin, Tsugiko Oze, Naoki Hiramatsu, Tetsuo Takehara, Akinori Kasahara, Kazuhiro Katayama, Michio Kato, Norio Hayashi, Involvement of dendritic cell frequency and function in virological relapse in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients, Journal of Medical Virology, 2007, 79, 5
  29. 29
    John G. McHutchison, Keyur Patel, Paul Pockros, Lisa Nyberg, Stephen Pianko, Rosie Z. Yu, F. Andrew Dorr, T. Jesse Kwoh, A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients, Journal of Hepatology, 2006, 44, 1, 88

    CrossRef

  30. 30
    Philippe Halfon, Guillaume Pénaranda, Marc Bourlière, Hacène Khiri, Marie-France Masseyeff, Denis Ouzan, Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: Implications for clinical management of patients with chronic hepatitis C virus infection, Journal of Medical Virology, 2006, 78, 2
  31. 31
    Ming-Lung Yu, Wan-Long Chuang, Chia-Yen Dai, Li-Po Lee, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Wen-Yu Chang, Sun-Lung Tsai, Hsing-Tao Kuo, Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy, Translational Research, 2006, 148, 3, 120

    CrossRef

  32. 32
    Anne Boulestin, Nassim Kamar, Karine Sandres-Sauné, Florence Legrand-Abravanel, Laurent Alric, Jean-Pierre Vinel, Lionel Rostaing, Jacques Izopet, Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon, Journal of Medical Virology, 2006, 78, 3
  33. 33
    Vicente Carreño, Javier Bartolomé, Inmaculada Castillo, Congenital and Other Related Infectious Diseases of the Newborn, 2006,

    CrossRef

  34. 34
    Nobuhiko Hiraga, Fumitaka Suzuki, Norio Akuta, Yoshiyuki Suzuki, Hitomi Sezaki, Tetsuya Hosaka, Takashi Someya, Masahiro Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Marie Matsuda, Sachiko Watabiki, Junko Satoh, Hiromitsu Kumada, Clinical and virological characteristics of untreated patients with chronic hepatitis C who develop serum alanine aminotransferase flare-up, Journal of Medical Virology, 2005, 75, 2
  35. 35
    Rasa Bertuzis, Alison Hardie, Barbara Hottentraeger, Jacques Izopet, Wolfgang Jilg, Barbara Kaesdorf, Gregor Leckie, Jean Leete, Luc Perrin, Chunfu Qiu, Iris Ran, George Schneider, Peter Simmonds, John Robinson, Clinical performance of the LCx® HCV RNA quantitative assay, Journal of Virological Methods, 2005, 123, 2, 171

    CrossRef

  36. 36
    Akihito Tsubota, Yasuji Arase, Takashi Someya, Yoshiyuki Suzuki, Fumitaka Suzuki, Satoshi Saitoh, Kenji Ikeda, Norio Akuta, Tetsuya Hosaka, Masahiro Kobayashi, Hiromitsu Kumada, Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naïve patients infected with hepatitis C virus of genotype 1b and high viral load, Journal of Medical Virology, 2005, 75, 1
  37. 37
    Maria H. Sjogren, Robert Sjogren, Kent Holtzmuller, Bradley Winston, Betty Butterfield, Stanley Drake, Amber Watts, Robin Howard, Milton Smith, Interferon Alfacon-1 and Ribavirin Versus Interferon ?-2b and Ribavirin in the Treatment of Chronic Hepatitis C, Digestive Diseases and Sciences, 2005, 50, 4, 727

    CrossRef

  38. 38
    Elena Rodríguez-Iñigo, Juan Manuel López-Alcorocho, Javier Bartolomé, Nuria Ortiz-Movilla, Margarita Pardo, Vicente Carreño, Percentage of Hepatitis C Virus-Infected Hepatocytes Is a Better Predictor of Response Than Serum Viremia Levels, The Journal of Molecular Diagnostics, 2005, 7, 4, 535

    CrossRef

  39. 39
    Michael P Manns, Adherence to combination therapy: influence on sustained virologic response and economic impact, Gastroenterology Clinics of North America, 2004, 33, 1, 11

    CrossRef

  40. 40
    T. Watkins-Riedel, P. Ferenci, P. Steindl-Munda, M. Gschwantler, C. Mueller, M. Woegerbauer, Early Prediction of Hepatitis C Virus (HCV) Infection Relapse in Nonresponders to Primary Interferon Therapy by means of HCV RNA Whole-Blood Analysis, Clinical Infectious Diseases, 2004, 39, 12, 1754

    CrossRef

  41. 41
    Mark W. Russo, Michael W. Fried, Guidelines for stopping therapy in chronic hepatitis C, Current Gastroenterology Reports, 2004, 6, 1, 17

    CrossRef

  42. 42
    Gregor Leckie, George Schneider, Klara Abravaya, Robert Hoenle, Julie Johanson, John Lampinen, Reuben Ofsaiof, Lisa Rundle, Shruti Shah, Andrea Frank, Dan Toolsie, Roy Vijesurier, Hong Wang, John Robinson, Performance attributes of the LCx® HCV RNA quantitative assay, Journal of Virological Methods, 2004, 115, 2, 207

    CrossRef

  43. 43
    F.Xavier López-Labrador, Xiao-Song He, Marina Berenguer, Ramsey C. Cheung, Teresa L. Wright, Harry B. Greenberg, The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8+ T cells in patients with chronic infection, Journal of Immunological Methods, 2004, 287, 1-2, 91

    CrossRef

  44. 44
    Alexander C. Haushofer, Harald H. Kessler, Encyclopedia of Medical Genomics and Proteomics, 2004,

    CrossRef

  45. 45
    R. Stefan Ross, Encyclopedia of Medical Genomics and Proteomics, 2004,

    CrossRef

  46. 46
    Jonathan C Anderson, Josephine Simonetti, Dennis G Fisher, James Williams, Yasuhiro Yamamura, Nayra Rodriguez, Daniel G Sullivan, David R Gretch, Brian McMahon, Kandace J Williams, Comparison of different HCV viral load and genotyping assays, Journal of Clinical Virology, 2003, 28, 1, 27

    CrossRef

  47. 47
    John G McHutchison, Michael W Fried, Current therapy for hepatitis C: pegylated interferon and ribavirin, Clinics in Liver Disease, 2003, 7, 1, 149

    CrossRef

  48. 48
    Lorraine Comanor, David Hendricks, Hepatitis C virus RNA tests: performance attributes and their impact on clinical utility, Expert Review of Molecular Diagnostics, 2003, 3, 6, 689

    CrossRef

  49. 49
    Kenneth D. Phillips, Robyn Brewer, Pathophysiology of Hepatitis C and HIV Coinfection, Journal of the Association of Nurses in AIDS care, 2003, 14, 5, 27S

    CrossRef

  50. 50
    Jean-Baptiste Nousbaum, Jean-François Cadranel, Olivier Savary, Marie Christine Legrand, Patrice Dumouchel, Hervé Gouérou, Sustained virological response after a short course of treatment with interferon and ribavirin in two chronic hepatitis C patients, Journal of Hepatology, 2003, 39, 4, 655

    CrossRef

  51. 51
    Mazen Alsatie, Paul Y. Kwo, Treatment of chronic hepatitis C in patients who have failed to respond to IFN or IFN and ribavirin combination therapy, Current Hepatitis Reports, 2003, 2, 1, 32

    CrossRef

  52. 52
    Gary L. Davis, Treatment of chronic hepatitis C: Improved combination therapy, Current Hepatitis Reports, 2003, 2, 1, 40

    CrossRef

  53. 53
    Jean-Michel Pawlotsky, Use and interpretation of hepatitis C virus diagnostic assays, Clinics in Liver Disease, 2003, 7, 1, 127

    CrossRef

  54. 54
    Thierry Poynard, Man-Fung Yuen, Vlad Ratzin, Ching Lung Lai, Viral hepatitis C, The Lancet, 2003, 362, 9401, 2095

    CrossRef

  55. 55
    A Scott Muerhoff, George J. Dawson, Viral Hepatitis: Molecular Biology, Diagnosis, Epidemiology and Control, 2003,

    CrossRef

  56. 56
    Kenneth E. Sherman, Susan D. Rouster, Paul S. Horn, Comparison of Methodologies for Quantification of Hepatitis C Virus (HCV) RNA in Patients Coinfected with HCV and Human Immunodeficiency Virus, Clinical Infectious Diseases, 2002, 35, 4, 482

    CrossRef

  57. 57
    Ayaz M Majid, David R Gretch, Current and future hepatitis C virus diagnostic testing: problems and advancements, Microbes and Infection, 2002, 4, 12, 1227

    CrossRef

  58. 58
    Wolfgang Jessner, Thomas Watkins-Riedel, Elisabeth Formann, Petra Steindl-Munda, Peter Ferenci, Hepatitis C viral dynamics: basic concept and clinical significance, Journal of Clinical Virology, 2002, 25, 31

    CrossRef

  59. 59
    Thierry Poynard, John McHutchison, Michael Manns, Christian Trepo, Karen Lindsay, Zachary Goodman, Mei–Hsiu Ling, Janice Albrecht, Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C, Gastroenterology, 2002, 122, 5, 1303

    CrossRef

  60. 60
    Karen L. Lindsay, Introduction to therapy of hepatitis C, Hepatology, 2002, 36, S1
  61. 61
    Jean–Michel Pawlotsky, Molecular diagnosis of viral hepatitis, Gastroenterology, 2002, 122, 6, 1554

    CrossRef

  62. 62
    R.S Ross, S Viazov, S Sarr, S Hoffmann, A Kramer, M Roggendorf, Quantitation of hepatitis C virus RNA by third generation branched DNA-based signal amplification assay, Journal of Virological Methods, 2002, 101, 1-2, 159

    CrossRef

  63. 63
    T.Casanovas Taltavull, Tratamiento de la recidiva de la hepatitis C postrasplante hepático. Influencia del tratamiento inmunodepresor en los resultados, Gastroenterología y Hepatología, 2002, 25, 4, 280

    CrossRef

  64. 64
    Jean-Michel Pawlotsky, Use and interpretation of virological tests for hepatitis C, Hepatology, 2002, 36, S1
  65. 65
    JEFFREY J. GERMER, NIZAR N. ZEIN, Advances in the Molecular Diagnosis of Hepatitis C and Their Clinical Implications, Mayo Clinic Proceedings, 2001, 76, 9, 911

    CrossRef

  66. 66
    Jeffrey J. Germer, Nizar N. Zein, Advances in the Molecular Diagnosis of Hepatitis C and Their Clinical Implications, Mayo Clinic Proceedings, 2001, 76, 9, 911

    CrossRef

  67. 67
    Marina Berenguer, F.Xavier López-Labrador, Teresa L. Wright, Hepatitis C and liver transplantation, Journal of Hepatology, 2001, 35, 5, 666

    CrossRef

  68. 68
    Paul A Jorgensen, Paul D Neuwald, Standardized hepatitis C virus RNA panels for nucleic acid testing assays, Journal of Clinical Virology, 2001, 20, 1-2, 35

    CrossRef

  69. 69
    John Levis, Elizabeth Kenny-Walsh, Kathleen O'Sullivan, Mary Horgan, Michael Whelton, Fergus Shanahan, Liam Fanning, Strategy for the maximization of clinically relevant information from hepatitis C virus, RT-PCR quantification, Journal of Clinical Virology, 2001, 20, 3, 163

    CrossRef

  70. 70
    Stefan Zeuzem, THE KINETICS OF HEPATITIS C VIRUS INFECTION, Clinics in Liver Disease, 2001, 5, 4, 917

    CrossRef

  71. 71
    Rafael Amaro, Eugene R. Schiff, Viral hepatitis, Current Opinion in Gastroenterology, 2001, 17, 3, 262

    CrossRef

  72. 72
    Johannes Wiegand, Thomas Berg, Individually Tailored Treatment Strategies in Treatment-naïve Chronic Hepatitis C Genotype 1 Patients,
  73. 73
    M Simin, D Stimac, C Gluud, Pegylated interferon alpha 2a versus pegylated interferon alpha 2b for acute and chronic hepatitis C, The Cochrane Library,
  74. 74
    Tahany Awad, Kristian Thorlund, Goran Hauser, Mahasen Mabrouk, Davor Stimac, Christian Gluud, Pegylated interferon alpha 2a versus pegylated interferon alpha 2b for chronic hepatitis C, The Cochrane Library,
  75. 75
    Marija Simin, Robert P Myers, Davor Stimac, Christian Gluud, Pegylated interferon for acute hepatitis C, The Cochrane Library,
  76. 76
    Marija Simin, Jesper Brok, Davor Stimac, Christian Gluud, Lise Lotte Gluud, Pegylated interferon plus ribavirin versus non-pegylated interferon plus ribavirin for chronic hepatitis C, The Cochrane Library,